Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

May 9, 2008
Bioniche Reports Fiscal 2008 Third Quarter

April 21, 2008
Bioniche Appoints U.S. President of Food Safety

Investors

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Bioniche Life Sciences Inc. is a leading, fully-integrated biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.

 

News Releases

To receive our news releases directly, please enter your e-mail address here.

Latest News

May 9, 2008
Bioniche Reports Fiscal 2008 Third Quarter more...

April 21, 2008
Bioniche Appoints U.S. President of Food Safety more...

April 18, 2008
Bioniche Reports the Passing of its Board Chair more...

More News

Category: 


Bioniche Key Facts

Founded: 1979

President & CEO:
Graeme McRae

TSX stock symbol:
BNC

Fiscal year-end:
June 30

2006 revenues:
C$26.7 million

Headquarters:
Belleville, Ontario

Employees worldwide:
188

Business divisions:
Human Health,
Animal Health,
Food Safety

Focus areas:
Human Health:
cancer, immunomodulation

Animal Health:
reproduction, vaccines, replacement of antibiotics

Food Safety: E. coli O157 vaccine, other veterinary biopharmaceutical products to address diseases in livestock which may have an effect on human health

Top products:

Animal Health:
Folltropin®, MAP 5®

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy